Inherited, congenital and acquired disorders by hemostasis (vascular, platelet & plasmatic phases) with repercussions in the therapeutic oral sphere

被引:8
作者
Arrieta-Blanco, Juan-Jose [1 ]
Onate-Sanchez, Ricardo [2 ]
Martinez-Lopez, Federico [2 ]
Onate-Cabrerizo, Daniel [2 ]
Cabrerizo-Merino, Maria-del Carmen [2 ]
机构
[1] Autonom Univ Madrid, Jimenez Diaz Capio Foundation, Odontostomatol Serv, Madrid, Spain
[2] Univ Odontol Clinic, Fac Medicine, Docent Unit Special Patients, Murcia, Spain
来源
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL | 2014年 / 19卷 / 03期
关键词
Hemostasis disorder; oral care protocols; haemorrhagic and thrombotic disorders; haemophilia; von willebrand disease; desmopressin; purple; thrombocytopenia; thrombocytopathies; RECOMBINANT FACTOR-VIIA; VON-WILLEBRAND DISEASE; BLEEDING DISORDERS; HEMOPHILIA; MANAGEMENT; SURGERY; AGGREGATION; INHIBITORS;
D O I
10.4317/medoral.19560
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The hemostasis alterations, either congenital or hereditary origin, and acquired, are circumstances that hinder oral care to patients who suffer them and also generates in the professional who has to attend, high stress. Bleeding control once established and dental treatment planning, both in the aspect of preparation, as the realization of the odonto-stomatological therapeutic, has suffered updates that do need to remember certain aspects of the care of these patients. But we must not forget that the hematologist or internist who controls the patient's medical condition, is a cornerstone for the planning and implementation of treatment plans. We must also remember that, in certain circumstances, treatment should be performed in a hospital setting. In this review, we aim to provide the odonto-stomatologist guidance on how to address the problem and provide simple and updated guidelines to apply in the treatment of these people.
引用
收藏
页码:E280 / E288
页数:9
相关论文
共 36 条
[1]  
Adeyemo Titilope A, 2011, Indian J Dent Res, V22, P454, DOI 10.4103/0970-9290.87070
[2]   Hypercoagulable States [J].
Anderson, Julia A. M. ;
Weitz, Jeffrey I. .
CRITICAL CARE CLINICS, 2011, 27 (04) :933-+
[3]  
Urdaneta MB, 2008, MED ORAL PATOL ORAL, V13, pE303
[4]   Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela [J].
Boadas, A. ;
Fernandez-Palazzi, F. ;
de Bosch, N. B. ;
Cedeno, M. ;
Ruiz-Saez, A. .
HAEMOPHILIA, 2011, 17 (03) :422-427
[5]   Hemostatic Management in Pediatric Patients With Type I von Willebrand Disease Undergoing Oral Surgery: Case Report and Literature Review [J].
Bornert, Fabien ;
Clauss, Francois ;
Gros, Catherine-Isabelle ;
Faradji, Albert ;
Schmittbuhl, Matthieu ;
Maniere, Marie-Cecile ;
Feki, Ahmed .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2011, 69 (08) :2086-2091
[6]  
Chiono O, 1968, Anesth Prog, V15, P295
[7]   Recombinant factor VIIa (Eptacog Alfa) - A review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders [J].
Croom, Katherine F. ;
McCormack, Paul L. .
BIODRUGS, 2008, 22 (02) :121-136
[8]   Approach to the assessment of platelet function: Comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods [J].
Dyszkiewicz-Korpanty, AM ;
Frenkel, EP ;
Sarode, R .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2005, 11 (01) :25-35
[9]   Advances in childhood vasculitis [J].
Eleftheriou, Despina ;
Dillon, Michael J. ;
Brogan, Paul A. .
CURRENT OPINION IN RHEUMATOLOGY, 2009, 21 (04) :411-418
[10]   Laboratory Investigation of Thrombophilia: The Good, the Bad, and the Ugly [J].
Favaloro, Emmanuel J. ;
McDonald, David ;
Lippi, Giuseppe .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (07) :695-710